Statement of Organization, Functions, and Delegations of Authority, 48427-48428 [2018-20835]
Download as PDF
<![CDATA[
48427
Federal Register / Vol. 83, No. 186 / Tuesday, September 25, 2018 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondents
AGE passenger and crew
cases.
Total ..................................
71.21(c) Recordkeeping—medical records (Interviews with
AGE crew case cabin mates and immediate contacts to determine AGE illness status and documentation of interview
dates/times).
71.21(c) Documentation of 3-day pre-embarkation AGE illness
assessment for all crew members.
71.21(c) Recordkeeping—medical records (Documentation of
3-day pre-embarkation AGE illness assessment for all crew
members).
71.21(c) Documentation of date/time of last symptom and
clearance to return to work for food and nonfood employees.
71.21(c) Recordkeeping—medical records (Documentation of
date/time of last symptom and clearance to return to work
for food and nonfood employees).
71.21(c) Recordkeeping—medical records (72 hour food/activity histories).
71.21(c) 72-hour food/activity history .........................................
....................................................................................................
Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–20808 Filed 9–24–18; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period;
withdrawal.
AGENCY:
The Centers for Disease
Control and Prevention (CDC) in the
Department of Health and Human
Services (HHS) announces the
withdrawal of the notice published
under the same title on September 7,
2018 for public comment.
DATES: The Centers for Disease Control
and Prevention is withdrawing the
notice published September 7, 2018 (83
FR 45444) as of September 25, 2018.
FOR FURTHER INFORMATION CONTACT:
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: On
September 7, 2018, CDC published a
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY:
17:40 Sep 24, 2018
Jkt 244001
4
250
5
3/60
62.5
250
1
1/60
4
250
1
3/60
12.5
250
1
1/60
4
250
1
1/60
4
5,000
1
10/60
833
........................
........................
........................
1,537
notice in the Federal Register titled
‘‘National Healthcare Safety Network
(NHSN)’’ (Vol. 83, No. 174 Docket No.
CDC–2018–0042, Pages 45444–45447).
This notice was published
inadvertently. The notice is being
withdrawn immediately for public
comment.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 74 FR 52816, dated
October 14, 2009) is amended to reflect
the reorganization of the Centers for
Disease Control and Prevention (CDC).
This reorganization is being undertaken
to increase scientific capacity;
strengthen infrastructure; create
efficiencies across the organization; and
improve the links between the national
centers.
PO 00000
Frm 00019
Fmt 4703
Sfmt 4703
Total burden
(in hours)
1/60
BILLING CODE 4163–18–P
Agency Forms Undergoing Paperwork
Reduction Act Review; Withdraw
Average
burden per
response
(in hours)
1
[FR Doc. 2018–20809 Filed 9–24–18; 8:45 am]
[60Day-18–0666]
Number of
responses per
respondent
250
Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
Number of
respondents
Form name
I. Under Part C, Section C–B,
Organization and Functions, the
following organizational units are
deleted in their entirety:
• Office of the Associate Director for
Laboratory Science and Safety (CAC)
• Office of the Associate Director for
Science (CAS)
• Office of the Associate Director for
Minority Health and Health Equity
(CAW)
• Office of State, Tribal, Local and
Territorial Support (CP)
• Office of Public Health Preparedness
and Response (CQ)
II. Under Part C, Section C–B,
Organization and Functions, make the
following changes:
• Retitle all references to the Office of
the Associate Director for Policy
(CAQ) to the Office of the Associate
Director for Policy and Strategy (CAQ)
• Retitle all references to the Office of
Public Health Scientific Services (CP)
to the Deputy Director for Public
Health Science and Surveillance (CP)
• Retitle all references to the Office of
Noncommunicable Diseases, Injury
and Environmental Health (CU) to the
Deputy Director for Non-Infectious
Diseases (CU)
• Retitle all references to the Office of
Infectious Diseases (CV) to the Deputy
Director for Infectious Diseases (CV)
III. Under Part C, Section C–B,
Organization and Functions, insert the
following:
• Deputy Director for Public Health
Service and Implementation Science
(CB): The Deputy Director for Public
Health Service and Implementation
Science leads, promotes, and facilitates
science, programs and policies to
identify and respond to public health
E:\FR\FM\25SEN1.SGM
25SEN1
daltland on DSKBBV9HB2PROD with NOTICES
48428
Federal Register / Vol. 83, No. 186 / Tuesday, September 25, 2018 / Notices
threats, both domestically and
internationally to its components,
which are as follows:
Æ Center for Global Health (CBB)
Æ Center for Preparedness and Response
(CBC)
Æ Center for State, Tribal, Local and
Territorial Support (CBD)
Æ Office of Minority Health and Health
Equity (CBE)
• Deputy Director for Public Health
Science and Surveillance (CP): The
Deputy Director for Public Health
Science and Surveillance leads,
promotes, and facilitates science,
surveillance, standards and policies to
reduce the burden of diseases in the
United States and globally to its
components, which are as follows:
Æ National Center for Health Statistics
(CPC)
Æ Center for Surveillance,
Epidemiology, and Laboratory
Services (CPN)
Æ Office of Science (CPP)
Æ Office of Laboratory Science and
Safety (CPQ)
• Deputy Director for Non-Infectious
Diseases (CU): The Deputy Director for
Non-Infectious Diseases reduces the
burden of non-infectious diseases,
injuries, birth defects, disabilities and
environmental health hazards to its
components, which are as follows:
Æ National Center on Birth Defects and
Developmental Disabilities (CUB)
Æ National Center for Chronic Disease
Prevention and Health Promotion
(CUC)
Æ National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry (CUG)
Æ National Center for Injury Prevention
and Control (CUH)
• Deputy Director for Infectious
Diseases (CV): Deputy Director for
Infectious Diseases leads, promotes, and
facilitates science, programs, and
policies to reduce the burden of
infectious disease in the United States
and globally and its components, which
are as follows:
Æ National Center for Immunization and
Respiratory Diseases (CVG)
Æ National Center for Emerging and
Zoonotic Infectious Diseases (CVL)
Æ National Center for HIV/AIDS, Viral
Hepatitis, STD and TB Prevention
IV. Delegations of Authority: All
delegations and redelegations of
authority made to officials and
employees of affected organizational
components will continue in them or
their successors pending further
redelegation, provided they are
consistent with this reorganization.
Authority: 44 U.S.C. 3101.
VerDate Sep<11>2014
17:40 Sep 24, 2018
Jkt 244001
Dated: August 17, 2018.
Alex M. Azar II,
Secretary.
[FR Doc. 2018–20835 Filed 9–24–18; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–18–0891]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled World Trade
Center Health Program Enrollment,
Treatment, Appeals & Reimbursement to
the Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on May 11, 2018, to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
PO 00000
Frm 00020
Fmt 4703
Sfmt 4703
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
World Trade Center Health Program
Enrollment, Treatment, Appeals &
Reimbursement (OMB Control No.
0920–0891, Expires 09/30/2018)—
Revision—National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
NIOSH seeks to request OMB
approval to revise the currently
approved information collection
activities that support the World Trade
Center (WTC) Health Program. The
James Zadroga 9/11 Health and
Compensation Act of 2010 (Pub. L. 111–
347, as amended by Pub. L. 114–113)
created the WTC Health Program to
provide medical monitoring and
treatment benefits to eligible individuals
affected by the terrorist attacks on
September 11, 2001. Eligible individuals
include firefighters and related
personnel, law enforcement officers,
and rescue, recovery, and cleanup
workers who responded to the attacks in
New York City, at the Pentagon, and in
Shanksville, Pennsylvania (responders),
and to eligible persons who were
present in the dust or dust cloud on
September 11, 2001, or who worked,
resided, or attended school, childcare,
or adult daycare in the New York City
disaster area (survivors).
This request also seeks to incorporate
information collection previously
approved under the World Trade Center
Health Program Petition for the
Addition of a New WTC-Related Health
Condition for Coverage under the World
Trade Center (WTC) Health Program
(OMB No. 0920–0929, expiration date 7/
31/2018), which has been discontinued.
The revision of OMB No. 0920–0891
will provide a comprehensive summary
of information collection needed to
administer the World Trade Center
Health Program.
Since its inception in 2011, the WTC
Health Program has been approved to
collect information from applicants and
Program members (enrolled WTC
responders and survivors) concerning
eligibility and enrollment, appointment
of a designated representative, medical
care, travel reimbursement, and appeal
E:\FR\FM\25SEN1.SGM
25SEN1
]]>Agencies
[Federal Register Volume 83, Number 186 (Tuesday, September 25, 2018)]
[Notices]
[Pages 48427-48428]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-20835]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 74 FR 52816, dated October 14, 2009) is
amended to reflect the reorganization of the Centers for Disease
Control and Prevention (CDC). This reorganization is being undertaken
to increase scientific capacity; strengthen infrastructure; create
efficiencies across the organization; and improve the links between the
national centers.
I. Under Part C, Section C-B, Organization and Functions, the
following organizational units are deleted in their entirety:
Office of the Associate Director for Laboratory Science and
Safety (CAC)
Office of the Associate Director for Science (CAS)
Office of the Associate Director for Minority Health and
Health Equity (CAW)
Office of State, Tribal, Local and Territorial Support (CP)
Office of Public Health Preparedness and Response (CQ)
II. Under Part C, Section C-B, Organization and Functions, make the
following changes:
Retitle all references to the Office of the Associate Director
for Policy (CAQ) to the Office of the Associate Director for Policy and
Strategy (CAQ)
Retitle all references to the Office of Public Health
Scientific Services (CP) to the Deputy Director for Public Health
Science and Surveillance (CP)
Retitle all references to the Office of Noncommunicable
Diseases, Injury and Environmental Health (CU) to the Deputy Director
for Non-Infectious Diseases (CU)
Retitle all references to the Office of Infectious Diseases
(CV) to the Deputy Director for Infectious Diseases (CV)
III. Under Part C, Section C-B, Organization and Functions, insert
the following:
Deputy Director for Public Health Service and
Implementation Science (CB): The Deputy Director for Public Health
Service and Implementation Science leads, promotes, and facilitates
science, programs and policies to identify and respond to public health
[[Page 48428]]
threats, both domestically and internationally to its components, which
are as follows:
[cir] Center for Global Health (CBB)
[cir] Center for Preparedness and Response (CBC)
[cir] Center for State, Tribal, Local and Territorial Support (CBD)
[cir] Office of Minority Health and Health Equity (CBE)
Deputy Director for Public Health Science and Surveillance
(CP): The Deputy Director for Public Health Science and Surveillance
leads, promotes, and facilitates science, surveillance, standards and
policies to reduce the burden of diseases in the United States and
globally to its components, which are as follows:
[cir] National Center for Health Statistics (CPC)
[cir] Center for Surveillance, Epidemiology, and Laboratory Services
(CPN)
[cir] Office of Science (CPP)
[cir] Office of Laboratory Science and Safety (CPQ)
Deputy Director for Non-Infectious Diseases (CU): The
Deputy Director for Non-Infectious Diseases reduces the burden of non-
infectious diseases, injuries, birth defects, disabilities and
environmental health hazards to its components, which are as follows:
[cir] National Center on Birth Defects and Developmental Disabilities
(CUB)
[cir] National Center for Chronic Disease Prevention and Health
Promotion (CUC)
[cir] National Center for Environmental Health/Agency for Toxic
Substances and Disease Registry (CUG)
[cir] National Center for Injury Prevention and Control (CUH)
Deputy Director for Infectious Diseases (CV): Deputy
Director for Infectious Diseases leads, promotes, and facilitates
science, programs, and policies to reduce the burden of infectious
disease in the United States and globally and its components, which are
as follows:
[cir] National Center for Immunization and Respiratory Diseases (CVG)
[cir] National Center for Emerging and Zoonotic Infectious Diseases
(CVL)
[cir] National Center for HIV/AIDS, Viral Hepatitis, STD and TB
Prevention
IV. Delegations of Authority: All delegations and redelegations of
authority made to officials and employees of affected organizational
components will continue in them or their successors pending further
redelegation, provided they are consistent with this reorganization.
Authority: 44 U.S.C. 3101.
Dated: August 17, 2018.
Alex M. Azar II,
Secretary.
[FR Doc. 2018-20835 Filed 9-24-18; 8:45 am]
BILLING CODE 4160-18-P
